Antithrombotic Therapy for Prevention of Cerebral Thromboembolic Events After Transcatheter Aortic Valve Replacement: Evolving Paradigms and Ongoing Directions.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

7 citing papers in PubMed.

1. Left Atrial Appendage Occlusion Using the Amplatzer Amulet Device in High-Risk Patients With Atrial Fibrillation Undergoing Transcatheter Aortic Valve Intervention: A Randomized Pilot Study.Structural heart : the journal of the Heart Team · 2025
   Article
2. Aortic stenosis and Heyde's syndrome: A comprehensive review.World journal of clinical cases · 2021
   Review
3. Rationale and design of the ADAPT-TAVR trial: a randomised comparison of edoxaban and dual antiplatelet therapy for prevention of leaflet thrombosis and cerebral embolisation after transcatheter aortic valve replacement.BMJ open · 2021
   Article
4. Dual-pathway inhibition for secondary and tertiary antithrombotic prevention in cardiovascular disease.Nature reviews. Cardiology · 2020
   Review
5. Anticoagulation after Transcatheter Aortic Valve Implantation: Current Status.Interventional cardiology (London, England) · 2020
   Review
6. Aspirin-free strategies in cardiovascular disease and cardioembolic stroke prevention.Nature reviews. Cardiology · 2018
   Review
7. Antithrombotic therapy after transcatheter aortic valve implantation: a new piece of the still unresolved puzzle.Journal of thoracic disease · 2017
   Article

Corrections and comments

• Comment on
  Aspirin Versus Aspirin Plus Clopidogrel as Antithrombotic Treatment Following Transcatheter Aortic Valve Replacement With a Balloon-Expandable Valve: The ARTE (Aspirin Versus Aspirin + Clopidogrel Following Transcatheter Aortic Valve Implantation) Randomized Clinical Trial.2017

Authors and funding

2 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as